Healthcare
Live Price
Offline$52.36
+7.38% today
1Y Change
+897.33%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Spruce Biosciences, Inc. (SPRB) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $52.36 and up 897.3% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +47.5%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +47.5%, free cash flow +40.4% with operating margin 0.0% and ROIC -84.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SPRB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SPRB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SPRB Max Drawdown
-98.96%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SPRB and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.